Navigation Links
CEL-SCI Corporation Announces 2007 Financial Results
Date:1/14/2008

VIENNA, Va., Jan. 14 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (Amex: CVM) reports financial results for the fiscal year ending September 30, 2007.

CEL-SCI reports a net operating loss for fiscal year 2007 of $9,352,209 versus a net operating loss of $5,349,196 in fiscal year 2006. The loss per share for fiscal year 2007 was unchanged at $(0.10) compared to fiscal year 2006.

The cash from operating activities used during the year was about $4,890,100. CEL-SCI's assets during the year grew from $9.6 million in fiscal year 2006 to $20.7 million in fiscal year 2007.

Geert Kersten, Chief Executive Officer said, "CEL-SCI had a very successful year in that it received FDA go-ahead for a Phase III clinical trial with its cancer drug Multikine, raised substantial amounts of money and began building a dedicated manufacturing facility for Multikine. We are looking forward to taking over the completed facility in 2008 and starting the global Phase III trial."

About CEL-SCI's Phase III Cancer Drug Multikine:

In Phase II clinical trials Multikine was shown to be safe and well- tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer.
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
2. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
3. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
8. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
9. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
10. Immunosyn Corporation Releases SF-1019 Study Results
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  AbbVie (NYSE: ... amounts pursuant to its previously announced offer to acquire ... ("Pharmacyclics") for a mix of cash and AbbVie common ... S-4 filed with the Securities and Exchange Commission by ... the assumption that the exchange offer will expire at ...
(Date:5/21/2015)... May 21, 2015 Delcath Systems, Inc. (NASDAQ: ... study cohort of its expanded Global Phase 2 Clinical ... of  patients with unresectable hepatocellular carcinoma (primary liver cancer, ... study will be conducted at the same hospitals in ... Phase 2 HCC trial, and ICC enrollment is now ...
(Date:5/21/2015)... , May 21, 2015 Dipexium ... stage pharmaceutical company focused on the development and ... research collaborators, today announced a scientific poster presentation ... 3 pivotal trials evaluating Locilex®, its novel, broad ... patients with mild infections of diabetic foot ulcers ...
Breaking Medicine Technology:AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 2ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 3ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 2Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 3Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 4Dipexium Announces Presentation at 7th International Symposium on the Diabetic Foot 5
... reached listeners in nine,cities across the United States, ... Adams,Morning Show and nine Radio One gospel radio ... Radiothon on Thursday, April 3,2008, benefiting St. Jude ... United States, the national fundraiser helped raise,awareness for ...
... be Presented at European Association for the Study of the ... Liver Annual ... that it has completed its Phase 2 study of its lead,compound, MitoQ(R) ... The European Association for the Study of the Liver,(EASL) Annual Meeting, being ...
Cached Medicine Technology:The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 2The Yolanda Adams Morning Show and Radio One Gospel Stations Raise More Than $1 Million During National Radiothon Benefiting St. Jude 3Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R) 2
(Date:5/21/2015)... 21, 2015 WellCare Health Plans, Inc. (NYSE: ... selected by the Florida Healthy Kids Corporation (FHKC) to continue ... age, as part of the Florida Healthy Kids (FHK) program. ... 2015, and may be extended for two additional years at ... children in the FHK program who live in Regions 1, ...
(Date:5/21/2015)... How do you stop head lice epidemics ... and school administrators, but a Miami Lice Removal Company, Lice ... southern Florida, is devising new ways to stop the spread. ... you, the first step is education and prevention. Despite the ... and how they spread are still widely misunderstood. Many continue ...
(Date:5/21/2015)... Many probiotics taken to promote gut ... celiac disease according to a new study by ... tested in the study contained gluten, a protein that ... cause gastrointestinal inflammation for those suffering from celiac disease ... trust in gluten-free claims have turned to global public ...
(Date:5/21/2015)... Angeles, CA (PRWEB) May 21, 2015 LOS ... Driver), the nation’s largest designated driver service, today announced the ... during the Memorial Day weekend. All new customers will receive ... and will be entered to win the grand prize of ... , Memorial Day weekend, traditionally viewed as the start of ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 The potentially ... a substance that seep out of plastic consumables unnoticed—are ... , Leachables can, however, adversely affect experiments and may ... by, for instance, inhibiting enzyme activities in bioassays or ... , Eppendorf is sponsoring a new, free educational ...
Breaking Medicine News(10 mins):Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:BeMyDD Announces Memorial Day Weekend Campaign to Decrease Drunk Driving Nationwide 2Health News:Eppendorf Webinar Shows How Consumables Can Impact Outcomes in Life Science Research 2Health News:Eppendorf Webinar Shows How Consumables Can Impact Outcomes in Life Science Research 3
... that less antibiotic used in food animals leads to ... a policy of restricting antibiotic use in food-producing animals ... drug-resistant bacteria found in its citizens. ,The ... the leading causes of food borne illness in industrialized ...
... in the April issue of Archives of Dermatology, almost 50% ... advertisements in their newspapers. // Tanning advertisements have been found ... all, there were about 40 tanning advertisements, 15 of whom ... to four months. ,The article carries related information ...
... a process by which a small protein acts directly ... fat while simultaneously suppressing appetite. // This discovery could ... ,The new study by a team led by a ... protein acts directly within muscles to increase the body's ...
... A 12-year-old schoolgirl Hannah Clark from Mountain Ash in South ... had her first heart transplant ten years ago, carried out ... good health with the donor heart that Sir Magdi had ... Magdi as an unusual case decided to leave Hannah's original ...
... dialysis unit at Swaroop Rani Nehru Hospital (SRN hospital) ... with kidney failure //. Two old dialysis machines have ... been installed. ,Following inspection by the Medical ... two new dialysis machines. The patients are being charged ...
... It has been revealed through a study by neuroscientists ... that long-term exposure to stress hormone in mice directly ... depression. April issue of Behavioral Neuroscience, which is published ... ,This would be helpful in treating depression in ...
Cached Medicine News:Health News:Antibiotics Used In Food Animals Causes Antibiotic Resistance In People 2Health News:A Protein May Help In Weight Loss Treatment 2Health News:Reverse Heart Transplant Surgery On A Little Girl Makes History 2Health News:Link Between Stress Hormone And Depression Revealed 2
... mid-sized chest freezer utilizes ultra-thin vacuum ... capacity without increasing the footprint. Patented ... extends compressor life. Bright LED display ... provided for remote user-supplied monitoring system. ...
... The NU-5510 DHD AutoFlow Direct Heat ... filtration guarantying the greatest control of ... both at 95C wet decontamination and ... exceptionally useful for cell line changes ...
... uses ultra-thin vacuum insulation panel technology, ... to increase storage capacity, while maintaining ... boxes or 3,336 samples. Patented heat ... consumption and extends compressor life. Temperature ...
... Series CO2 Incubators by Cedco ... achieves precise temperature and CO2 ... & RH% is displayed digitally. ... RH are displayed digiton large, ...
Medicine Products: